Table 2 Results of the univariate analysis
Categorical Variables | PWV (mean±SD) | p-value |
|---|---|---|
Gender | 0.439T | |
Male | 8.9±1.5 | |
Female | 9.2±1.2 | |
Exercise | 0.009T | |
Yes | 8.5±1.3 | |
No | 9.6±1.4 | |
Pre-diabetes subcategory | 0.215A | |
IFG | 8.8±1.1 | |
IGT | 9.5±2.2 | |
IFG+IGT | 9.4±1.4 | |
Use of statins | 0.656T | |
Yes | 9.3±1.3 | |
No | 9.0±1.5 | |
Continuous Variables | PWV (mean±SD) | r§ (p-value) |
Age (years) | +0.522 (0.0001) | |
<48 | 8.5±0.9 | |
≥48 | 9.6±1.6 | |
MBP (mmHg) | +0.428 (0.002) | |
<106.3 | 8.1±0.8 | |
≥106.3 | 10.0±1.3 | |
Total cholesterol (mg/dL) | +0.601 (<0.0001) | |
<196 | 8.2±1.1 | |
≥196 | 9.9±1.2 | |
LDL (mg/dL) | +0.672 (<0.0001) | |
<118.4 | 8.0±0.7 | |
≥118.4 | 10.1±1.2 | |
GFR (mL/min) | −0.491 (0.0003) | |
<77 | 9.6±1.3 | |
≥77 | 8.5±1.3 | |
ADMA (μmol/L) | +0.508 (0.0002) | |
<0.757 | 8.1±0.8 | |
≥0.757 | 9.8±1.3 | |
BMI (kg/m2) | −0.164 (0.254) | |
<32.9 | 9.2±1.3 | |
≥32.9 | 9.0±1.6 | |
WHR | +0.154 (0.284) | |
<0.91 | 8.8±1.2 | |
≥0.91 | 9.4±1.6 | |
CD34+KDR+ (cells/mL) | −0.121 (0.403) | |
<292 | 9.3±1.5 | |
≥292 | 8.9±1.4 | |
HOMA-IR | +0.218 (0.128) | |
<4.51 | 9.0±1.4 | |
≥4.51 | 9.2±1.5 | |
Fasting glucose (mg/dL) | +0.449 (0.001) | |
<107 | 8.6±1.7 | |
≥107 | 9.5±1.0 | |
HbA1c (%) | +0.006 (0.967) | |
<6 | 9.0±1.2 | |
≥6 | 9.2±1.6 | |
hs-CRP (mg/L) | +0.018 (0.907) | |
<3.89 | 8.9±1.5 | |
≥3.89 | 9.4±1.4 |